Event Title Go back to Home Page
Event Summary  
Event Type Medicine - Pharmaceutical Recalls  Date Time 2019-11-12 22:34:00 
Country US  City Bridgewater, NJ 
Latitude 40.594  Longitude -74.605 
URL https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/amneal-pharmaceuticals-llc-issues-voluntary-nationwide-recall-ranitidine-tablets-usp-150mg-and-300mg     
[fda.com] NEW JERSEY - Amneal Pharmaceuticals LLC Issues Voluntary Nationwide Recall Of Ranitidine Tablets USP 150mg And 300mg And Ranitidine Syrup - Ranitidine Oral Solution USP 15 mg-mL Due To Possible Presence Of N-nitrosodimethylamine NDMA Impurity

"Amneal Pharmaceuticals, LLC. Bridgewater, New Jersey is voluntarily recalling Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL to the consumer level."

Read the full article:



Copyright © 2006-2012  All Rights Reserved.